Abstract
Significant synthesis of Human Serum Albumin (HSA) was demonstrated in E. coli using efficient bacterial expression signals. The recombinant HSA is produced essentially as an insoluble aggregate and differs from natural HSA by the presence of a methionine at the N-terminus. However, the Met-HSA could be re-natured, purified and was found to be very similar to the natural protein. A procedure was devised to produce mature HSA starting with the authentic N-terminal sequence from E. coli. By analogy with the maturation of the HSA propeptide, a plasmid expressing a fusion between the first six residues of the bacteriophage λcII protein (Val-Arg-Ala-Asn-Lys-Arg-) and the sequence of mature HSA was constructed. After renaturation, this fusion protein was cleaved by trypsin in vitro to yield a mature refolded HSA with native N-terminal sequence. This protein could not be distinguished by several criteria from authentic natural HSA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Peters, T. Jr. 1985. Serum albumin. Adv. Prot. Chem. 37: 161–245.
Meloun, B., Moravek, L., and Kostka, V. 1975. Complete amino acid sequence of human serum albumin. FEES Lett. 58: 134–137.
Strauss, A.W., Donohue, A.M., Bennett, C.D., Rodkey, J.A. and Alberts, A.W. 1977. Rat liver preproalbumin: In vitro synthesis and partial amino acid sequence. Proc. Natl. Acad. Sci. USA 74: 1358–1362.
Judah, J.D. and Quinn, P.S. 1978. Calcium ion-dependent vesicle fusion in the conversion of proalbumin to albumin. Nature 271: 384–385.
Brennan, S., Owen, M., Boswell, D., Lewis, J. and Carrell, R. 1984. Circulating proalbumin associated with a variant proteinase inhibitor. Biochim. Biophys. Acta 802: 24–28.
Jeans, E.R.A., Marshall, P.J., and Lowe, C.R. 1985. Plasma protein fractionation. Trends Biotechnol. 3: 267–270.
Lawn, R.M., Adelman, J., Bock, S., Franke, A., Houck, C., Najarian, R., Seeburg, P., and Wion, L. 1981. The sequence of human serum albumin cDNA and its expression in E. coli. Nuc. Acids. Res. 9: 6103–6114.
Dugaiczyk, A., Law, S.W. and Dennison, O.E. 1982. Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc. Natl. Acad. Sci. USA 79: 71–75.
Delbrück, M. 1946. Bacterial viruses or bacteriophages. Biol. Rev. 21: 30–40.
Boss, M.A., Kenten, J.H., Wood, C.R., and Emtage, J.S. 1984. Assembly of functional antibodies from immunoglobulin heavy and light chains synthesized in E. coli. Nuc. Acids. Res. 12: 3791–3806.
Bernard, H.U., Remaut, E., Hershfield, M.V., Das, H., and Helinski, D. 1979. Construction of plasmid vehicles that promote gene expression from the bacteriophage lambda PL promoter. Gene 5: 59–76.
Hsu, S.M., Raine, L. and Fanger, H. 1981. Use of Avidin-Biotin-Peroxidase complexe (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577–580.
Kenten, J., Helm, B., Ishizaka, T., Cattini, P., and Gould, H. 1984. Properties of a human immunoglobulin ε-chain fragment synthesised in E. coli. Proc. Natl. Acad. Sci. USA 81: 2955–2959.
Emtage, J.S., Angal, S., Doel, M.T., Harris, T.J.R., Jenkins, B., Lilley, G., and Lowe, P.A. 1983. Synthesis of calf prochymosin (prorennin) in E. coli. Proc. Natl. Acad. Sci. USA 80: 3671–3675.
Simons, G., Remaut, E., Allet, B., Devos, R., and Fiers, W. 1984. High level expression of human interferon gamma in E. coli under control of the PL promoter of bacteriophage lambda. Gene 28: 55–64.
Peters, T. 1975. Serum albumin, p. 133–181. In: The Plasma Proteins, Vol. I Putnam, F. W. (ed.). Academic Press, New York.
Taylor, R. 1977. Enzyme-like activities associated with albumin, p.183–201. In: Albumin Structure, Function and Uses. Rosenoer, V., Oratz, M., Rothschild, M. (ed.): Pergamon Press Inc.
Riddles, B.W., Blakeley, R.L., and Zerner, B. 1983. Reassessment of Ellman's reagent. Methods in Enzymology. 91: 49–60.
Teale, J.M. and Benjamin, D.C. 1976. Antibody as an immunological probe for studying the refolding of bovine serum albumin. J. Biol. Chem. 251: 4603–4608.
Ben-Bassat, A. and Bauer, K. 1987. Amino-terminal processing of proteins. Nature 326: 315.
Carter, P., Bedouelle, H., and Winter, G. 1985. Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nuc. Acids. Res. 13: 4431–4443.
Bruns, W., Hoppe, J., Tsai, H., Brüning, H.J., Maywald, F., Collins, J., and Mayer, H. 1985. Structure of the penicillin acylase gene from E. coli: A periplasmic enzyme that undergoes multiple proteolytic processing. J. Mol. Appl. Genetics 3: 36–44.
Sekizawa, J., Inouye, S., Halegoua, S., and Inouye, M. 1977. Precursors of major outer membrane proteins of E. coli. Biochem. Biophys. Res. Commun. 77: 1126–1133.
Brennan, S.O. and Carrell, R. 1978. A circulating variant of human proalbumin. Nature 274: 908–909.
Gorini, L. and Audrain, L. 1956. Relations entre degré de renaturation et sensibilityé à la trypsine de la sérum albumine. Influence de Ca++ et de Mn++ et rôle des ponts disulfure. Biochim. Biophys. Acta 19: 289–296.
Courtney, M., Jallat, S., Tessier, L-H., Benavente, A., and Crystal, R.G. 1985. Synthesis in E. coli of α1-antitrypsin variants of therapeutic potential for emphysema and thrombosis. Nature 313: 149–151.
Nagai, K. and Thøgersen, H.C. 1984. Generation of β-globin by sequence specific proteolysis of a hybrid protein produced in E. coli. Nature 309: 810–812.
Lau, S-J. and Sarkar, B. 1975. Kinetics studies of copper (II)-exchange from L-histidine to human serum albumin and diglycyl-L-histidine, a peptide mimicking the copper (II)-transport site of albumin. Can. J. Chem. 53: 710–715.
Glennon, J.D. and Sarkar, B. 1982. Nickel(II) transport in human blood serum. Studies of Nickel(II) binding to human albumin and to native-sequence peptide, and ternary complex formation with L-histidine. Biochem. J. 203: 15–23.
Brennan, S.O. and Carrell, R. 1980. Functional abnormality of proalbumin Christchurch. Biochim. Biophys. Acta 621: 83–88.
Klausner, A. 1985. Adjustment in the blood fraction market. Bio/Technology 3: 119–125.
Becker, G.W. and Hsiung, H.M. 1986. Expression, secretion and folding of human growth hormone in E. coli. FEBS Lett. 204: 145–150.
Gray, G.L., Baldridge, J.S., McKeown, K.S., Heyneker, H.L., and Nan Chang, C. 1985. Periplasmic production of correctly processed human growth hormone in E. coli: Natural and bacterial signal sequences are interchangeable. Gene 39: 247–254.
Liang, S-M., Allet, B., Rose, K., Hirschi, M., Liang, C-M., and Thatcher, D.R. 1985. Characterization of human interleukin 2 derived from E. coli. Biochem J. 229: 429–439.
Dalbøge, H., Dahl, H-H.M., Pedersen, J., Hansen, J. W., and Christensen, T. 1987. A novel enzymatic method for production of authentic hGH from an E. coli produced hGH-precursor. Bio/Technology 5: 161–164.
Ben-Bassat, A., Bauer, K., Chang, S-Y., Myambo, K., Boosman, A., and Chang, S. 1987. Processing of the initiation methionine from proteins: Properties of the E. coli methionine aminopeptidase and its gene structure. J. Bacteriol. 169: 751–757.
Germino, J. and Bastia, D. 1984. Rapid purification of a cloned gene product by genetic fusion and site-specific proteolysis. Proc. Natl. Acad. Sci. USA 81: 4692–4696.
Chance, R.E., Hoffman, J.A., Kroeff, E.P., Johnson, M.G., Schimer, E.W., Bromer, W.W., Ross, M.J., and Wetzel, R. 1981. The production of human insulin using recombinant DNA technology and a new chain combination procedures, p. 721–728 In: Peptides: Synthesis-Structure-Function. Rich, D. H. and Gross, E. (eds.): Pierce Chemical Co.
Abrahmsén, L., Moks, T., Nilson, B., and Uhlén, M. 1986. Secretion of heterologous gene products to the culture medium of E. coli. Nuc. Acids Res. 14: 7487–7500.
Varadarajan, R., Szabo, A., and Boxer, S.G. 1985. Cloning, expression in E. coli, and reconstitution of human myoglobin. Proc. Natl. Acad. Sci. USA 82: 5681–5684.
Sarmientos, P., Sylvester, J.E., Contente, S., and Cashel, M. 1983. Differential stringent control of the tandem E. coli ribosomal RNA promoters from the rrnA operon expressed in vivo in multicopy plasmids. Cell 32: 1337–1346.
Genetica. 1985. Process for microbiological preparation of human serum albumin. EP 0 198 745 A1 (European Patent Application).
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
Messing, J. 1983. New M13 vectors for cloning. Methods in Enzymology 101: 20–79.
Adelman, J.P., Hayflick, J.S., Vasser, M., and Seeburg, P.H. 1983. In vitro deletional mutagenesis for bacterial production of the 20,000-Dalton form of human pituitary growth hormone. DNA 2: 183–193.
Miller, J.H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory Cold Spring Harbor, NY.
Saunders, C.W., Schmidt, B.J., Mallonee, R.L., and Guyer, M.S. 1987. Secretion of Human Serum Albumin from Bacillus subtilis. J. Bacteriol. 169: 2917–2925.
Etcheverry, T., Forrester, W., and Hitzeman, R. 1986. Regulation of the chelatin promoter during the expression of human serum albumin or yeast phosphoglycerate kinase in yeast. Bio/Technology 4: 726–730.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Latta, M., Knapp, M., Sarmientos, P. et al. Synthesis and Purification of Mature Human Serum Albumin from E. Coli. Nat Biotechnol 5, 1309–1314 (1987). https://doi.org/10.1038/nbt1287-1309
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1287-1309
This article is cited by
-
Expression of human serum albumin in the milk of transgenic mice
Transgenic Research (1992)